Taylor Corbitt, Partner, Riley Safer Holmes & Cancila LLP to Speak at The Knowledge Group’s Live Webcast
The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Taylor Corbitt, Partner, Riley Safer Holmes & Cancila LLP will speak at a 2-hour webcast entitled “Strategic Patent Portfolio and Lifecycle Development for Pharma & Biotech Industries Significant Issues LIVE Webcast” This two-hour event is scheduled on January 12, 2017 @ 12:00pm - 12:00pm ET.
New York, NY, January 04, 2017 --(PR.com)-- The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Taylor Corbitt, Partner, Riley Safer Holmes & Cancila LLP will speak at a 2-hour webcast entitled “Strategic Patent Portfolio and Lifecycle Development for Pharma & Biotech Industries Significant Issues Live Webcast” This two-hour event is scheduled on January 12, 2017 @ 12:00pm - 12:00pm ET.
Event Summary:
In a highly competitive and constantly changing market of today, the pharmaceutical industry is looking for suitable ways to extend the profitability of its products up to and beyond patent expiry, so medical device IP Portfolios are becoming increasingly relevant for pharma. Due to the expensive cost associated with the Research and Development (R&D), it is becoming crucial to implement integrated Life Cycle Management (LCM) strategies that would maximize revenues and extend the lifespan of patent portfolios. In cases where patent extension is not an option, and the product is nearing patent cliff, drug innovators are increasingly relying upon medical device IP to decelerate the pace of revenue loss from generic competition.
Without strong product LCM strategies, pharmaceutical companies are more likely to be exposed to legal challenges and revenue risks. In this two-hour live webcast, a stellar panel assembled by The Knowledge Group will offer a discussion on the most significant issues involving patent portfolio and LCM strategies. The panel will also provide a roadmap through the R&D process and will help the audience understand the best practices in minimizing the risks associated with patent portfolio and lifecycle development.
Key Issues:
· Pharmaceutical and Medical Device Patent Life Cycles – An Overview
· Patent Term Adjustments for Biotech and Pharma
· Role of PTA in Medical Device and Pharma Patent Life Cycle
· Patent Term Extension
· Patentability and Implications for Life Sciences Innovation
· Portfolio Strategies
· Common Risks and Pitfalls
· Up-to-the-minute Regulatory Updates
About Taylor Corbitt
Taylor Corbitt is an intellectual property and patent litigator at Riley Safer Holmes & Cancila LLP. Taylor has nearly a decade of experience with patent portfolio planning and counselling, managing prosecution of chemical, biotech and pharmaceutical portfolios, clearance and freedom-to-operate opinions, IP due diligence, pre-litigation analysis, litigation, and proceedings before the Patent Trials and Appeal Board of the U.S. Patent and Trademark Office. Taylor’s practice focuses on chemical and pharmaceutical technologies, but she also represents clients in patent litigation concerning technologies related to consumer products, mechanical devices, and computer methods. Taylor is a graduate of DePaul University College of Law. She received a degree in molecular biology from the University of Virginia. Taylor has been named an Emerging Lawyer in Intellectual Property Law and Patent Law by Law Bulletin Publishing Company’s Leading Lawyers in 2015 and 2016.
About Riley Safer Holmes & Cancila LLP
Riley Safer Holmes & Cancila LLP is a diverse, service-oriented and technically sophisticated national litigation practice committed to providing legal and client service at the highest levels in the profession. Our partners offer decades of experience and feature leaders in class action, white collar, intellectual property, product liability, employment law and general litigation. Our teams of seasoned and capable attorneys in Chicago, San Francisco and New York, represent and serve the interests of valued clients around the world.
About The Knowledge Group, LLC/The Knowledge Congress Live Webcast Series
The Knowledge Congress is a series of live webcasts produced by The Knowledge Group, LLC, which examine trends, regulatory, and technology changes across a variety of industries. Its mission is to produce unbiased, objective, and educational live webcasts that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format.
The organization brings together the world's leading authorities and industry participants through informative two-hour webcasts to study the impact of changes and emerging trends. Hear from leading government officials/regulators, key thought leaders, and industry experts objectively analyze the latest trends and issues and their impact on industries.
Event Summary:
In a highly competitive and constantly changing market of today, the pharmaceutical industry is looking for suitable ways to extend the profitability of its products up to and beyond patent expiry, so medical device IP Portfolios are becoming increasingly relevant for pharma. Due to the expensive cost associated with the Research and Development (R&D), it is becoming crucial to implement integrated Life Cycle Management (LCM) strategies that would maximize revenues and extend the lifespan of patent portfolios. In cases where patent extension is not an option, and the product is nearing patent cliff, drug innovators are increasingly relying upon medical device IP to decelerate the pace of revenue loss from generic competition.
Without strong product LCM strategies, pharmaceutical companies are more likely to be exposed to legal challenges and revenue risks. In this two-hour live webcast, a stellar panel assembled by The Knowledge Group will offer a discussion on the most significant issues involving patent portfolio and LCM strategies. The panel will also provide a roadmap through the R&D process and will help the audience understand the best practices in minimizing the risks associated with patent portfolio and lifecycle development.
Key Issues:
· Pharmaceutical and Medical Device Patent Life Cycles – An Overview
· Patent Term Adjustments for Biotech and Pharma
· Role of PTA in Medical Device and Pharma Patent Life Cycle
· Patent Term Extension
· Patentability and Implications for Life Sciences Innovation
· Portfolio Strategies
· Common Risks and Pitfalls
· Up-to-the-minute Regulatory Updates
About Taylor Corbitt
Taylor Corbitt is an intellectual property and patent litigator at Riley Safer Holmes & Cancila LLP. Taylor has nearly a decade of experience with patent portfolio planning and counselling, managing prosecution of chemical, biotech and pharmaceutical portfolios, clearance and freedom-to-operate opinions, IP due diligence, pre-litigation analysis, litigation, and proceedings before the Patent Trials and Appeal Board of the U.S. Patent and Trademark Office. Taylor’s practice focuses on chemical and pharmaceutical technologies, but she also represents clients in patent litigation concerning technologies related to consumer products, mechanical devices, and computer methods. Taylor is a graduate of DePaul University College of Law. She received a degree in molecular biology from the University of Virginia. Taylor has been named an Emerging Lawyer in Intellectual Property Law and Patent Law by Law Bulletin Publishing Company’s Leading Lawyers in 2015 and 2016.
About Riley Safer Holmes & Cancila LLP
Riley Safer Holmes & Cancila LLP is a diverse, service-oriented and technically sophisticated national litigation practice committed to providing legal and client service at the highest levels in the profession. Our partners offer decades of experience and feature leaders in class action, white collar, intellectual property, product liability, employment law and general litigation. Our teams of seasoned and capable attorneys in Chicago, San Francisco and New York, represent and serve the interests of valued clients around the world.
About The Knowledge Group, LLC/The Knowledge Congress Live Webcast Series
The Knowledge Congress is a series of live webcasts produced by The Knowledge Group, LLC, which examine trends, regulatory, and technology changes across a variety of industries. Its mission is to produce unbiased, objective, and educational live webcasts that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format.
The organization brings together the world's leading authorities and industry participants through informative two-hour webcasts to study the impact of changes and emerging trends. Hear from leading government officials/regulators, key thought leaders, and industry experts objectively analyze the latest trends and issues and their impact on industries.
Contact
The Knowledge Group
Thomas LaPointe, Jr., Executive Director
646-844-0200
www.theknowledgegroup.org
Therese Lumbao, Director
Account Management & Member Services
tlumbao@knowledgecongress.org
Contact
Thomas LaPointe, Jr., Executive Director
646-844-0200
www.theknowledgegroup.org
Therese Lumbao, Director
Account Management & Member Services
tlumbao@knowledgecongress.org
Categories